Dentalcare-aus The trusted resource for dental professionals

Re-examining the Plaque-Gingivitis Connection and the Role of Stannous Fluoride

A History and Update of Fluoride Dentifrices
Course Author(s): Sherri M. Lukes, RDH, MS, FAADH
CE Credits: 2 Hour(s)
Intended Audience: Dentists, Dental Hygienists, Dental Assistants, Dental Students, Dental Hygiene Students, Dental Assistant Students
Date Course Online: 01/03/2019
Last Revision Date: NA
Course Expiration Date: 28/02/2022
Cost: Free
Method: Self-instructional
AGD Subject Code(s): 490
Introduction - The Plaque-Gingivitis Connection

The purpose of Re-examining the Plaque-Gingivitis Connection and the Role of Stannous Fluoride is to review the role of plaque in the initiation of periodontal disease, share novel insights on the mechanism by which stannous fluoride reduces plaque-induced gingivitis, and discuss practical implications for dental professionals.

Conflict of Interest Disclosure Statement

  • The author has done consulting work for Procter & Gamble.

Disclaimer: Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy.

Note: Registration is required to take test.

Educators only! Use this feature to create assignments for your students.

CREATE ASSIGNMENT
TAKE COURSE NOW

ADA CERP Recognized Provider

The Procter & Gamble Company is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

Concerns or complaints about a dental CE provider may be directed to the provider or to ADA CERP at:
http://www.ada.org/cerp

ADA CERP

Approved PACE Program Provider

 

THE PROCTER & GAMBLE COMPANY
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority or AGD endorsement.
8/1/2021 to 7/31/2027
Provider ID# 211886